参考文献/References:
[1] PAPADOPOULOU A,BOUNTOUVI E,KARACHALIOU F E.The molecular basis of calcium and phosphorus inherited metabolic disorders[J].Genes (Basel),2021,12(5):734-738.
[2] WOUK N.End-stage renal disease:medical management[J].Am Fam Physician,2021,104(5):493-499.
[3] ROUMELIOTIS S,ROUMELIOTIS A,GORNY X,et al.Could antioxidant supplementation delay progression of cardiovascular disea-se in end-stage renal disease patients[J].Curr Vasc Pharmacol,2021,19(1):41-54.
[4] 徐钢.肾脏病诊疗指南[M].北京:科学出版社,2013:27-43.
XU G.Guidelines for diagnosis and treatment of nephropathy[M].Beijing:Science Press,2013:27-43.
[5] 国家肾脏疾病临床医学研究中心.中国慢性肾脏病矿物质和骨异常诊治指南概要[J].肾脏病与透析肾移植杂志,2019,28(1):52-57.
NATIONAL CLINICAL RESEARCH CENTER OF KIDNEY DISEASES.Summary of Chinese guidelines for the diagnosis and treatment of mineral and bone abnormalities in chronic kidney disease[J].J Nephrol Dialy Transplant,2019,28(1):52-57.
[6] RASTOGI A,BHATT N,ROSSETTI S,et al.Management of hyperphosphatemia in end-stage renal disease:a new paradigm[J].J Ren Nutr,2021,31(1):21-34.
[7] TRUYTS C,CUSTODIO M,PECOIT-FILHO R,et al.Cardiovascular mortality in peritoneal dialysis:the impact of mineral disorders[J].J Bras Nefrol,2021,43(2):182-190.
[8] 卢光娅,王淑华,赵子秀,等.腹膜透析与血液透析对尿毒症患者炎症细胞因子及钙磷代谢水平影响的对比研究[J].临床和实验医学杂志,2019,18(13):1417-1420.
LU G Y,WANG S H,ZHAO Z X,et al.A comparative study of the effects of peritoneal dialysis and hemodialysis on inflammatory cytokines and calcium and phosphorus metabolism in uremic patients[J].J Clin Exp Med,2019,18(13):1417-1420.
[9] DEBOWSKA M,GOMEZ R,PINTO J,et al.Phosphate clearance in peritoneal dialysis[J].Sci Rep,2020,10(1):17504-17509.
[10] DIAS D B,MENDES M L,CARAMORI J T,et al.Urgent-start dia-lysis:comparison of complications and outcomes between peritoneal dialysis and haemodialysis[J].Perit Dial Int,2021,41(2):244-252.
[11] RODRIGUES H C N,MARTINS T F P,SANTANA N C F E S,et al.Antioxidant and anti-inflammatory response to curcumin supplementation in hemodialysis patients:a randomized,double-blind,placebo-controlled clinical trial[J].Clin Nutr ESPEN,2021,44(11):136-142.
[12] 骆强,卿山林,尧鹏.血液透析、高通量血液透析及血液透析滤过治疗尿毒症患者的效果及对血清炎症因子、氧化应激指标的影响[J].临床误诊误治,2020,33(4):71-76.
LUO Q,QING S L,YAO P.Effects of hemodialysis,high-flux hemodialysis and hemodiafiltration on patients with uremia and its influence on serum inflammatory factors and oxidative stress indexes[J].Clin Misdiag Misther,2020,33(4):71-76.
[13] FORMAN H J,ZHANG H.Targeting oxidative stress in disease:promise and limitations of antioxidant therapy[J].Nat Rev Drug Discov,2021,20(9):689-709.
[14] INNICO G,GOBBI L,BERTOLDI G,et al.Oxidative stress,inflammation,and peritoneal dialysis:a molecular biology approach[J].Artif Organs,2021,45(10):1202-1207.
[15] ROUMELIOTIS S,DOUNOUSI E,SALMAS M,et al.Unfavorable effects of peritoneal dialysis solutions on the peritoneal membrane:the role of oxidative stress[J].Biomolecules,2020,10(5):768-772.
[16] 刘伯英,戴芳,康亚洁,等.腹膜透析与维持性血液透析对终末期肾病患者炎性因子肾功能及氧化应激的影响[J].中国药物与临床,2020,20(23):4011-4013.
LIU B Y,DAI F,KANG Y J,et al.Effects of peritoneal dialysis and maintenance hemodialysis on inflammatory factors,renal function and oxidative stress in patients with end-stage renal disease[J].Chin Remed Clin,2020,20(23):4011-4013.
相似文献/References:
[1]周长菊,章旭,曹娟,等.维持性血液透析患者采用不同血液净化方式心脏瓣膜钙化高危因素分析[J].新乡医学院学报,2012,29(04):000.
[2]任 伟,王玉梅,陈永健.老年糖尿病肾病患者血液透析相关肺炎危险因素分析[J].新乡医学院学报,2021,38(1):076.[doi:10.7683/xxyxyxb.2021.01.017]
REN Wei,WANG Yumei,CHEN Yongjian.Analysis of the risk factors of hemodialysis associated pneumonia in elderly patients with diabetic nephropathy[J].Journal of Xinxiang Medical University,2021,38(9):076.[doi:10.7683/xxyxyxb.2021.01.017]
[3]汪丽丽,孙娴静,张馨怡,等.罗沙司他联合蔗糖铁和促红细胞生成素治疗血液透析患者肾性贫血疗效观察[J].新乡医学院学报,2021,38(9):818.[doi:10.7683/xxyxyxb.2021.09.004]
WANG Lili,SUN Xianjing,ZHANG Xinyi,et al.Clinical effect of roxadustat combined with iron sucrose and erythropoietin in the treatment of renal anemia of hemodialysis patients[J].Journal of Xinxiang Medical University,2021,38(9):818.[doi:10.7683/xxyxyxb.2021.09.004]
[4]袁小强,张献朝,赵丽萍.西那卡塞和骨化三醇联合治疗糖尿病肾病血液透析患者继发性甲状旁腺功能亢进症疗效观察[J].新乡医学院学报,2022,39(2):131.[doi:10.7683/xxyxyxb.2022.02.006]
YUAN Xiaoqiang,ZHANG Xianchao,ZHAO Liping.Effect of cinacalcet and calcitriol in the treatment of secondary hyperparathyroidism in diabetic nephropathy patients undergoing hemodialysis[J].Journal of Xinxiang Medical University,2022,39(9):131.[doi:10.7683/xxyxyxb.2022.02.006]
[5]杨靖倩,狄亚妮,胡爽爽,等.终末期肾病患者腹膜透析后心血管疾病影响因素分析[J].新乡医学院学报,2023,40(4):333.[doi:10.7683/xxyxyxb.2023.04.007]
YANG Jingqian,DI Yani,HU Shuangshuang,et al.Analysis of influencing factors of cardiovascular disease in patients with end-stage renal disease after peritoneal dialysis[J].Journal of Xinxiang Medical University,2023,40(9):333.[doi:10.7683/xxyxyxb.2023.04.007]
[6]王岩,张爱霞,王紫晖,等.碱性成纤维细胞生长因子、血清和糖皮质激素诱导的蛋白激酶3表达与血液透析患者动静脉内瘘失功的关系[J].新乡医学院学报,2023,40(9):851.[doi:10.7683/xxyxyxb.2023.09.009]
WANG Yan,ZHANG Aixia,WANG Zihui,et al.Relationship between the expression of basic fibroblast growth factor,serum and glucocorticoid-induced protein kinase 3 and the dysfunction of arteriovenous fistula in patients undergoing hemodialysis[J].Journal of Xinxiang Medical University,2023,40(9):851.[doi:10.7683/xxyxyxb.2023.09.009]
[7]李会宁,黄智敏.高通量血液透析对老年终末期肾病患者氧化应激及微炎症状态的影响[J].新乡医学院学报,2023,40(11):1069.[doi:10.7683/xxyxyxb.2023.11.012]
LI Huining,HUANG Zhimin.Effect of high-flux hemodialysis on oxidative stress and microinflammatory status in elderly patients with end-stage renal disease[J].Journal of Xinxiang Medical University,2023,40(9):1069.[doi:10.7683/xxyxyxb.2023.11.012]